These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19474012)

  • 1. Secondary prevention in stroke. When we might extrapolate.
    Lewis LS
    BMJ; 2009 May; 338():b2097. PubMed ID: 19474012
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary prevention in stroke. Where's the evidence?
    Hepple PA
    BMJ; 2009 May; 338():b2095. PubMed ID: 19474011
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations of the second Indo-U.S. health summit on prevention and control of cardiovascular disease among Asian Indians.
    Enas EA; Singh V; Munjal YP; Gupta R; Patel KC; Bhandari S; Agarwal AK; Joshi SR; Anoop M; Prabhakaran D; Shah B; Reddy S; Sharma B; Trehan N; Yavagal ST; Kasliwal RR;
    Indian Heart J; 2009; 61(3):265-74. PubMed ID: 20503833
    [No Abstract]   [Full Text] [Related]  

  • 4. The young at risk of CVD are the least likely to receive preventive cardiovascular medications in New Zealand.
    Hobbs FD
    J Prim Health Care; 2011 Jun; 3(2):92. PubMed ID: 21625655
    [No Abstract]   [Full Text] [Related]  

  • 5. Views on lipid lowering. JUPITER seems to be bypassed.
    Murray SW
    BMJ; 2010 Oct; 341():c5835. PubMed ID: 20959303
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrate use in diabetes: new concepts.
    Bloomgarden ZT; Drexler A
    J Diabetes; 2011 Mar; 3(1):1-2. PubMed ID: 21159144
    [No Abstract]   [Full Text] [Related]  

  • 7. Niacin: the only vitamin that reduces cardiovascular events.
    Wierzbicki AS
    Int J Clin Pract; 2011 Apr; 65(4):379-85. PubMed ID: 21401825
    [No Abstract]   [Full Text] [Related]  

  • 8. [Eicosapentaenoic acid ethyl esters].
    Ohtsuka S
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():489-93. PubMed ID: 17824076
    [No Abstract]   [Full Text] [Related]  

  • 9. Application in general practice of treatment guidelines for patients with dyslipidaemia: the RESPECT study.
    Cacoub P; Tocque-Le Gousse E; Fabry C; Hermant S; Petzold L
    Arch Cardiovasc Dis; 2008; 101(11-12):715-21. PubMed ID: 19059566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Framing cardiovascular disease event risk prediction.
    Stone JA
    Can J Cardiol; 2011; 27(2):171-3. PubMed ID: 21459265
    [No Abstract]   [Full Text] [Related]  

  • 11. Triglycerides and cardiovascular risk.
    Jones A
    Heart; 2013 Jan; 99(1):1-2. PubMed ID: 23161618
    [No Abstract]   [Full Text] [Related]  

  • 12. [The factors that condition the efficacy of and indications for statins in cardiovascular prevention].
    Pintó Sala X
    Aten Primaria; 1999 Mar; 23(4):227-30, 232-4. PubMed ID: 10333608
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Medical dyslipidemia intervention and vascular residual risks reduction].
    Chen YQ; Zhao SP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):574-6. PubMed ID: 21033145
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of cardiovascular disease: plea for a rationale use of diet and lipid-lowering drugs.
    Scheen AJ
    Acta Clin Belg; 2003; 58(3):149-51. PubMed ID: 12945473
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment implication from the potential association between nonalcoholic fatty liver disease and cardiovascular disease.
    Shen L
    Hepatology; 2011 Jul; 54(1):377-8. PubMed ID: 21710476
    [No Abstract]   [Full Text] [Related]  

  • 18. UK review finds statins are cost effective in secondary prevention.
    Kmietowicz Z
    BMJ; 1999 Nov; 319(7222):1390. PubMed ID: 10574845
    [No Abstract]   [Full Text] [Related]  

  • 19. [What has changed in therapy of vascular patients (role of statins and beta-adrenoblockers)].
    Pokrovskiĭ AV; Goloviuk AL
    Angiol Sosud Khir; 2010; 16(2):7-11. PubMed ID: 21032867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.